Clinical presentation, shock severity and mortality in patients with de novo versus acute ‐on‐chronic heart failure‐related cardiogenic shock

ConclusionIn this large HF-CS cohort, acute-on-chronic HF-CS was associated with more severe CS and higher mortality risk compared to de novo HF-CS, although traditional markers of CS severity and use of treatments were comparable. These findings highlight the vast heterogeneity of patients with HF-CS, emphasize that HF chronicity is a relevant disease modifier in CS, and indicate that future clinical trials should account for this.This article is protected by copyright. All rights reserved.

Source: European Journal of Heart Failure - November 9, 2023 Category: Cardiology Authors: Jonas Sundermeyer, Caroline Kellner, Benedikt N. Beer, Lisa Besch, Angela Dettling, Letizia Fausta Bertoldi, Stefan Blankenberg, Jeroen Dauw, Zouhir Dindane, Dennis Eckner, Ingo Eitel, Tobias Graf, Patrick Horn, Joanna Jozwiak ‐Nozdrzykowsk Tags: Research Article Source Type: research